No­var­tis' TV ad for breast can­cer drug Kisqali draws un­ti­tled let­ter from FDA

The FDA sent No­var­tis a rep­ri­mand last week claim­ing “false or mis­lead­ing” in­for­ma­tion in a TV com­mer­cial for metasta­t­ic breast can­cer drug Kisqali. The TV …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER